Study guide

Reprocessed Dialyzers Where Applicable

CCHT Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Orientation, Eligibility, and Exam Strategy

Official Sources and Exam Purpose Eligibility, Application Documents, and Training Verification Exam Format, Fees, Scoring, Practice Exam, and Permit Timing Blueprint and Cognitive-Level Strategy State/Federal Compliance and CMS Context 4-8 Week Post-Training Study Plan

2 Kidney Disease, Hemodialysis Principles, and Adequacy

Kidney Functions and ESRD Basics Hemodialysis Goals and Transport Principles Uremia, Fluid Overload, Electrolytes, and Acid-Base Context Dialysis Adequacy: Kt/V, URR, Treatment Time, and Adherence Pre/Post Weights, Target Weight, and Fluid Gains Patient Education for Diet, Fluid, Medications, and Treatment Adherence

3 Clinical Assessment and Pre-Treatment Safety

Pre-Treatment Assessment and Vital Signs Access Assessment and Signs of Access Failure Fluid Status and Blood Pressure Relationship Prescription Verification and Treatment Setup Checks Aseptic Technique in Patient Care Red Flags Requiring RN Escalation Before Treatment

4 Vascular Access, Cannulation, and Treatment Initiation

AV Fistula, AV Graft, and Catheter Comparison Cannulation Principles, Needle Direction, and Asepsis Initiating Hemodialysis with AV Access Catheter Precautions and Facility Protocol Boundaries Heparin Protocol Awareness and Scope Boundaries Early Treatment Monitoring After Initiation

5 Treatment Monitoring, Complications, and Discontinuation

Intra-treatment Monitoring and Vital Signs Hypotension, Cramps, Nausea, Headache, and Chest Pain Blood Loss, Infiltration, Clotting, Air, Hemolysis, and Fever Volume Status and UF Troubleshooting Discontinuing Treatment and Post-Access Care Post-Treatment Assessment, Documentation, and Escalation

6 Labs, Medications, Specimens, and Patient Education

Common Dialysis Labs Specimen Processing and Chain of Custody Medication Awareness Within Technician Role Anemia, Mineral Bone, Nutrition, and Fluid Education Teach-Back and Scope Limits Documentation of Education and Abnormal Findings

7 Technical Systems, Extracorporeal Circuit, and Machine Operation

Extracorporeal Circuit Components Dialyzer, Blood Pump, Pressures, Air Detector, and Clamps Machine Setup According to Prescription Conductivity, Temperature, pH, and Independent Checks Alarm Recognition and First Safe Actions Equipment Adverse Events and Documentation

8 Water Treatment, Dialysate, Reuse, and Equipment Safety

Water Treatment Principles and Monitoring RO, Carbon, Softener, and Microbiology Concepts Dialysate Concentrates and Powder Mixing Disinfection, Cultures, and QC Checks Reprocessed Dialyzers Where Applicable Equipment Safety: Stop, Report, and Document

9 Environment, Infection Control, and Emergency Preparedness

Standard Precautions and Hand Hygiene PPE, Bloodborne Pathogens, Isolation, and Vaccinations Surface Disinfection, Spills, Waste, and Supplies Body Mechanics and Patient Transfer Safety Emergency Exits, Fire Safety, and Environmental Hazards Disasters, Water and Power Failures, and Communication

10 Role Responsibilities, Documentation, and Professional Communication

Scope and Team Roles Privacy, Dignity, Confidentiality, and Boundaries Verbal and Nonverbal Communication Documentation of Treatment Outcomes and Adverse Events Quality Improvement and Chain of Reporting Ethical Behavior and Patient Advocacy Within Role

11 Integrated CCHT Domain Review and High-Yield Scenarios

Mixed Clinical, Technical, Environment, and Role Scenarios Application-Level Item Strategy Blueprint-Weighted Practice Blocks High-Risk Distractors and Unsafe Shortcuts Error Log by Domain and Cognitive Level Final Weak-Domain Repair

12 Exam Day, Retesting, Recertification, and Career Next Steps

Final 30/14/7 Day Plan Exam-Day Checklist, ID, Permit, and Time Use Score Report, Subarea Breakdown, and Retest Planning Recertification Every Three Years by CE and Work Experience CCHT-A Pathway and Advanced Practice Considerations Maintaining Competence and Staying Within Rules

Reprocessed Dialyzers Where Applicable

Key Takeaways Explain This Topic AI

Dialyzer reuse is optional and governed by AAMI reprocessing standards and CMS rules; a reprocessed dialyzer is assigned to ONE patient and may never be used on another - patient mix-up is the catastrophic error.

Reprocessing cleans, tests, disinfects, labels, and stores the dialyzer; the key performance test is total cell volume (TCV), which must remain at least 80% of the original priming volume or the dialyzer is discarded.

Two independent germicide-removal verifications (presence/absence tests, e.g., for peracetic acid or formaldehyde) are required before a reprocessed dialyzer is connected, plus a rinse and air-free prime.

Before use, verify the patient-specific label, reuse count, appearance (clear fibers, no clots or dark bands), integrity (no leaks), storage/expiration, and a negative germicide test.

Any wrong label, failed test, leak, abnormal appearance, or patient reaction (fever, chills, chest/back pain, dyspnea, hemolysis signs) requires immediate escalation per protocol.

Last updated: June 2026

What Reprocessing Is and When It Applies

Dialyzer reprocessing (reuse) is the process of cleaning, testing, disinfecting, labeling, and storing a used dialyzer so it can be reused by the same patient at a later treatment. It is permitted only where the facility operates an approved reuse program that complies with AAMI reprocessing standards and CMS ESRD Conditions for Coverage (42 CFR 494) . Many U.S. units now use single-use dialyzers only , so a technician must never assume reuse rules apply in every setting.

The single most important safety principle: a reprocessed dialyzer is patient-specific . Each dialyzer carries a label with the patient's name, a second identifier, and the reuse count . Using one patient's dialyzer on another patient is a catastrophic, never-event error that can transmit bloodborne pathogens. Verifying the patient label against the patient's identity is non-negotiable.

Performance and Germicide Verification

Reprocessing must confirm the dialyzer still performs and is safe . The central performance test is total cell volume (TCV) - the volume of blood the fiber bundle holds. Clotting and fiber loss shrink the TCV and reduce clearance.

TCV must remain at least 80% of the original (baseline) volume. Below 80%, the dialyzer is discarded because it can no longer deliver the prescribed clearance.

A pressure/leak (integrity) test confirms no fiber or housing leaks that could cause blood loss or a membrane breach.

Disinfection uses a germicide such as peracetic acid (most common), formaldehyde , or glutaraldehyde , which must dwell for the required contact time and then be completely removed before reuse .

The germicide-removal rule is a frequent exam item: two independent presence/absence tests must confirm the germicide is gone before connecting the patient , in addition to a thorough rinse and an air-free prime . Residual peracetic acid or formaldehyde reaching the blood causes hemolysis, chemical reactions, and severe symptoms .

The Pre-Use Checklist and Reuse Risks

Before a reprocessed dialyzer is connected, the technician confirms every item:

  • Check What 'pass' looks like
  • Patient label Correct name + second identifier, matches the patient
  • Reuse count At or below the facility maximum
  • Appearance Clear, uniform fibers; no clots, dark bands, or discoloration
  • Integrity / leak test Passed; no leaks
  • Performance (TCV) >=80% of original volume
  • Germicide residual Negative on two independent tests
  • Storage / expiration Stored correctly; within shelf life

Benefits of reuse include supply and cost management and reduced first-use reactions , but the exam weights risk far more heavily. The serious hazards are patient mix-up, inadequate germicide removal, contamination/infection, a damaged or leaking membrane, and reduced clearance from a low TCV .

During treatment, watch for a reuse/first-use type reaction : unexplained fever, chills, chest or back pain, shortness of breath, hypotension, or signs of hemolysis (cherry-red or dark blood in the venous line, falling hematocrit). Any such finding requires immediate escalation per protocol - stop the suspected cause within scope, call the nurse, and document objective findings plus the dialyzer's identification.

Worked example: A technician picks up a reprocessed dialyzer and the label reads a different patient's name, even though the chair assignment is correct. The technician does not use it - a name mismatch is an absolute stop. The dialyzer is set aside, the nurse and reprocessing staff are notified, and the event is documented. Treating reuse dialyzers as interchangeable would risk a cross-patient exposure.

The Reprocessing Cycle, Step by Step

Understanding the order of reprocessing helps you see why each pre-use check exists. A typical cycle proceeds:

Rinse and clean - flush blood and debris from the blood and dialysate compartments immediately after treatment so proteins do not fix to the membrane.

Performance test (TCV) - measure total cell volume against the original baseline; discard if below 80%.

Integrity / leak test - pressure-test the fibers and housing for leaks.

Disinfect with germicide - fill with peracetic acid, formaldehyde, or glutaraldehyde for the required contact time.

Label and store - record patient name, reuse number, date, and operator; store in a controlled, dated location.

Pre-use checks - at the next treatment, verify label, germicide removal (two tests), appearance, and integrity before connecting.

Each step maps to a hazard: skip the rinse and you get inadequate cleaning and reactions; skip the TCV and you under-dialyze; skip the leak test and you risk blood loss or a membrane breach; skip the germicide-removal test and you expose blood to a caustic chemical.

Single-Use vs Reuse and the Scope Boundary

Because many facilities have moved to single-use dialyzers , the exam expects you to recognize that reuse rules apply only where an approved program exists - you never improvise reprocessing in a single-use unit, and you never apply single-use assumptions to a reuse dialyzer.

The trade-off is straightforward. Reuse offers cost and supply benefits and may reduce first-use reactions , but it introduces the dangers of patient mix-up, residual germicide, contamination, leaks, and declining clearance . The CCHT blueprint weights the risks heavily, so the safest answer almost always respects labeling, patient assignment, testing, storage, and facility policy over convenience.

The technician's scope is to verify and escalate , not to judge a borderline dialyzer fit for use against policy. A failed TCV, a positive germicide test, a leak, an abnormal appearance, a wrong label, or any patient reaction is a stop-and-escalate event - the dialyzer leaves service and qualified staff and the nurse are notified, with objective documentation of what was observed and the dialyzer's identifying information.